Saturday 21 December 2024
Salisbury Foundation Trust

FOI_7221

Internal Reference Number: FOI_7221

Date Request Received: 07/06/2023 00:00:00

Date Request Replied To: 30/06/2023 00:00:00

This response was sent via: By Email

Request Summary: biologic medicines in gastroenterology

Request Category: Companies

 
Question Number 1:
How many patients were treated in the last 3 months by the Gastroenterology department (for any medical condition) with the following biologic drugs:

• Adalimumab - Humira

• Adalimumab Biosimilar

• Filgotinib

• Golimumab

• Infliximab - Remicade

• Infliximab Biosimilar

• Ozanimod

• Tofacitinib

• Upadacitinib

• Ustekinumab

• Vedolizumab

• Vedolizumab Injections ONLY (pre-filled pens or syringes)
 
Answer To Question 1:
• Adalimumab – Humira 12

• Adalimumab Biosimilar 67

• Filgotinib 14

• Golimumab <5

• Infliximab – Remicade 15

• Infliximab Biosimilar 142

• Ozanimod 0

• Tofacitinib <5

• Upadacitinib <5

• Ustekinumab 48

• Vedolizumab 35

• Vedolizumab Injections ONLY (pre-filled pens or syringes) 17
 
Question Number 2:
If you are able to link patient treatment to a disease, could you please provide the number of patients treated in the last 3 months for Ulcerative Colitis ONLY with the following biologic drugs:

• Adalimumab - Humira

• Adalimumab Biosimilar

• Filgotinib

• Golimumab

• Infliximab - Remicade

• Infliximab Biosimilar

• Ozanimod

• Tofacitinib

• Upadacitinib

• Ustekinumab

• Vedolizumab

• Vedolizumab Injections ONLY (pre-filled pens or syringes)
 
Answer To Question 2:
• Adalimumab - Humira - 0

• Adalimumab Biosimilar - 7

• Filgotinib - 5

• Golimumab - <5

• Infliximab - Remicade - 6

• Infliximab Biosimilar - 71

• Ozanimod - 0

• Tofacitinib - 0

• Upadacitinib - 0

• Ustekinumab - 6

• Vedolizumab - 35

• Vedolizumab Injections ONLY (pre-filled pens or syringes) - 14
 
Question Number 3:
Does your trust participate in clinical trials for the treatment of Ulcerative Colitis? If so, please provide the total number of patients taking part in any Ulcerative Colitis study.
 
Answer To Question 3:
We have 0 clinical trials in this area.
 
To return to the list of all the FOI requests please click here

Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.

Person Centred & Safe

Professional

Responsive

Friendly

Progressive

Salisbury NHS Foundation Trust, Salisbury District Hospital, Odstock Road, Salisbury, Wiltshire, SP2 8BJ
T: 01722 336262 E: sft.pals@nhs.net
© 2024 Salisbury NHS Foundation Trust
Trust Values